Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
| Autor: | Layman, Rachel M *, Han, Hyo S, Rugo, Hope S, Stringer-Reasor, Erica M, Specht, Jennifer M, Dees, E Claire, Kabos, Peter, Suzuki, Samuel, Mutka, Sarah C, Sullivan, Brian F, Gorbatchevsky, Igor, Wesolowski, Robert |
|---|---|
| Zdroj: | In The Lancet Oncology April 2024 25(4):474-487 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|